Generation of T Cells of Desired HLA Restriction Specific for Epitopes of a Self-Antigen, WT1, for the Adoptive Immunotherapy of WT1 Positive Malignancies Using A Panel of Artificial Antigen Presenting Cells Expressing Prevalent HLA Alleles.

被引：0
|
作者：
Doubrovina, Ekaterina
Hasan, Aisha
Oflaz-Sozmen, Banu
Selvakumar, Annamalai [1 ]
Sadelain, Michel W. [2 ]
O'Reilly, Richard J. [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Ctr Cell Engn & Mol Pharmacol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Pediat BMT, New York, NY 10021 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1567 / 1568
页数：2
相关论文
共 41 条
  • [31] Adoptive Immunotherapy Following Umbilical Cord Blood Transplantation Using The Sleeping Beauty System and Artificial Antigen Presenting Cells To Generate Donor-Derived T Cells Expressing a CD19-Specific Chimeric Antigen Receptor
    Kebriaei, Partow
    Huls, Helen
    Singh, Harjeet
    Olivares, Simon
    Figliola, Matthew
    Kumar, Pappanaicken R.
    Jena, Bipulendu
    Jackson, Rineka N.
    Liu, Tingting
    McNiece, Ian K.
    Rondon, Gabriela
    Hackett, Perry
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Cooper, Laurence J. N.
    BLOOD, 2013, 122 (21)
  • [32] A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles
    Butler, Marcus O.
    Ansen, Sascha
    Tanaka, Makito
    Imataki, Osamu
    Berezovskaya, Alla
    Mooney, Mary M.
    Metzler, Genita
    Milstein, Matthew I.
    Nadler, Lee M.
    Hirano, Naoto
    INTERNATIONAL IMMUNOLOGY, 2010, 22 (11) : 863 - 873
  • [33] A phase I study of adoptive immunotherapy for advanced ROR1+malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)
    Specht, Jennifer M.
    Lee, Sylvia
    Turtle, Cameron J.
    Berger, Carolina
    Baladrishnan, Ashwini
    Srivastava, Shivani
    Voillet, Valentin
    Veatch, Josh
    Gooley, Ted
    Mullane, Erin
    Chaney, Colette
    Rader, Christoph
    Pierce, Robert H.
    Gottardo, Raphael
    Maloney, David G.
    Riddell, Stanley R.
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Co-Administration Of Gene-Modified CD4+ T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia
    Fujiwara, Hiroshi
    Ochi, Fumihiro
    Ochi, Toshiki
    Asai, Hiroaki
    Miyazaki, Yukihiro
    Azuma, Taichi
    Okamoto, Sachiko
    Mineno, Junichi
    Narita, Miwako
    Kuzushima, Kiyotaka
    Shiku, Hiroshi
    Yasukawa, Masaki
    BLOOD, 2013, 122 (21)
  • [35] Simultaneous in vitro generation of CD8 and CD4 T cells specific to three universal tumor associated antigens of WT1, survivin and TERT and adoptive T cell transfer for the treatment of acute myeloid leukemia
    Sohn, Hyun-Jung
    Lee, Ji Yoon
    Lee, Hyun-Joo
    Sohn, Dae-Hee
    Cho, Hyun-Il
    Kim, Hee-Je
    Kim, Tai-Gyu
    ONCOTARGET, 2017, 8 (27) : 44059 - 44072
  • [36] Adoptive Transfer Of WT-1 Specific HLA Class 2 Restricted Donor-Derived T-cells Induces Sustained Remission Of AML Relapse Post Transplant Presenting As Leukemia Cutis
    Prockop, Susan E.
    Doubrovina, Ekaterina
    Adams, Roberta
    Boulad, Farid
    Kernan, Nancy A.
    O'Reilly, Richard J.
    BLOOD, 2013, 122 (21)
  • [37] Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
    Romano, Emanuela
    Cotari, Jesse W.
    da Silva, Rosa Barreira
    Betts, Brian C.
    Chung, David J.
    Avogadri, Francesca
    Fink, Mitsu J.
    St Angelo, Erin T.
    Mehrara, Babak
    Heller, Glenn
    Muenz, Christian
    Altan-Bonnet, Gregoire
    Young, James W.
    BLOOD, 2012, 119 (22) : 5182 - 5190
  • [38] Identification of HLA-A0201 restricted epitope of cancer/testis antigen (CTA) Hormad1 and generation of antigen-specific T-cell receptor-engineered T cells (TCR-T) for treatment of solid tumor malignancies.
    Pan, Ke
    Chiu, Yulun
    Hasan, Farah
    Miroballi, Natalia
    Whitehurst, Angelique
    Yee, Cassian
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 65 - 66
  • [39] HLA-A*2402-restricted and WT1 235-243-specific T-cell receptor gene transduced CD4+T-cells diversely enhance the anti-leukaemia functionality mediated by similarly redirected CD8+T-cells using the identical TCR gene transfer
    Fujiwara, H.
    Ochi, T.
    Miyazaki, Y.
    Asai, H.
    Okamoto, S.
    Mineno, J.
    Kuzushima, K.
    Shiku, H.
    Yasukawa, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S325 - S325
  • [40] Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue
    Maeurer, MJ
    Necker, A
    Salter, RD
    Castelli, C
    Höhn, H
    Karbach, J
    Freitag, K
    Neukirch, C
    Knuth, A
    Jäger, E
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (01) : 64 - 71
12345